Category 2019
2H
2020
1H
2020
2H
2021
1H
2021
2H
Target indication
OPTA-INFLA
Acute inflammatory
disease
IV
Process dev.
PK & Tox
Non-Clinical Stage
IRI, transplantation, GvHD, or others
Chronic inflammatory
disease
SC
PK, Tox & Efficacy profiling
Process dev.
COPD, MS, or others
Oral
Process dev.
IBD
OPTA-ONCO
Drug delivery system IV
Process dev.
Process dev.
Cancer drug carrier
Discovery projects
Discovery projects
Discovery
TBD